Palmitoyl pentapeptide-4 explained: the research record

Prepared by: Research Desk. Sources are linked for verification.

Lab note: one ingredient, one paper trail. Matrixyl is one of the best-known names in cosmetic peptides, and serum boxes often use it as a selling point. A trade name is not an ingredient list, though.

This note does three things:

• It identifies the exact molecule behind the original Matrixyl.

• It sorts the research record by study type.

• It shows how to find the ingredient on a label.

For the bigger picture on how cosmetic peptides are grouped into families, see our lab notebook guide to peptides in skincare.

Entry 1: what the ingredient actually is

The original Matrixyl ingredient is palmitoyl pentapeptide-4. That is its INCI name (International Nomenclature of Cosmetic Ingredients), which is the name used on ingredient lists. In research papers it is often written as palmitoyl-KTTKS or Pal-KTTKS [1].

Here is how the name breaks down:

• Pentapeptide: a chain of five amino acids. They are lysine, threonine, threonine, lysine and serine, or K-T-T-K-S in one-letter code.

• Palmitoyl: a 16-carbon fatty-acid chain attached to one end. It is meant to make the water-loving peptide more compatible with the oily outer layer of skin, the stratum corneum.

• The "-4": a numbering suffix in the INCI system. It separates this molecule from other palmitoylated pentapeptides and says nothing about strength.

Cosmetic-science writing usually files palmitoyl pentapeptide-4 under signal peptides: ingredients proposed to send a message to skin cells to make more extracellular matrix proteins. The term is still in active use in delivery research, where "anti-photoaging signal peptides" are a named target [2]. Our pillar guide explains how signal peptides differ from the carrier, neurotransmitter-inhibiting and enzyme-inhibiting families.

A naming trap: products sold under related trade names (for example, versions with a number added after the name) may contain different peptides altogether. If a box names only the brand, the INCI list is the only reliable way to know which molecule is inside.

Entry 2: the human study most often cited

Most claims about this ingredient trace back to one paper: Robinson and colleagues, published in 2005 in the International Journal of Cosmetic Science [1]. As described in the published record, its key features are:

• Design: a double-blind, vehicle-controlled, split-face study. Each participant applied the peptide formulation to one side of the face and a matching formulation without the peptide to the other side.

• Participants: 93 adult women with photoaged facial skin.

• Duration: 12 weeks.

• What was measured: facial wrinkles and fine lines. These were assessed by quantitative technical image analysis and by expert graders assessing images.

• What was reported: the authors reported statistically significant differences favouring the peptide side over the vehicle side on wrinkle and fine-line measures. They also described the formulation as well tolerated [1].

How to weigh it, lab-notebook style:

1. It is one study. We could not find independent trials of the same design that confirm the result.

2. Industry context. The authors are listed with affiliations to a consumer-products company that sells skincare. That does not make the result wrong, but readers deserve to know it.

3. Appearance endpoints. The study measured how surface features of skin looked in images. That fits the cosmetic category. It did not measure skin structure.

4. Formulation matters. The result applies to the specific test formula. A different product containing this ingredient, at an undisclosed level and in a different base, cannot automatically claim the same result.

Entry 3: lab-only work (not human evidence)

Much of what is written about palmitoyl pentapeptide-4 comes from cell-culture or chemistry papers. These papers help explain how a molecule behaves. They do not show what happens on intact human skin.

• Signal-peptide theory. The idea that small matrix-derived peptides can signal cells to remodel tissue rests largely on laboratory models. A well-known example is the copper-binding tripeptide GHK, which Pickart discussed in the context of tissue remodelling [3]. Detailed copper-peptide coverage lives on our sister site. The point here is simply that signal-peptide theory depends heavily on lab work.

• New molecules from a related starting point. Chemists have used a collagenesis-inducing peptide as the starting point for new compounds. One 2019 laboratory study reported antibacterial and antibiofilm activity against multidrug-resistant Gram-negative bacteria for modified versions [4]. That finding is about new compounds made in a lab. It is not a property of the cosmetic ingredient in a serum.

Notebook rule: if a product page cites "studies" without saying whether they were done in cells, in skin models or in people, assume they were not done in people until shown otherwise.

Entry 4: the delivery question

The palmitoyl tail exists because peptides generally struggle to cross the stratum corneum. Two recent papers show the field is still working on this:

• A 2026 study examined how cosmetic actives permeate into the human stratum corneum, the skin's outermost layer [5].

• A 2025 paper described self-assembled nanomicelles designed to carry anti-photoaging signal peptides. It reported enhanced transdermal delivery in its experimental models [2].

Researchers are still designing delivery systems for signal peptides, and that tells you something. Getting a peptide through intact skin to its proposed target is not a solved problem.

Entry 5: safety assessment and regulatory status

Safety assessment. A 2026 paper in Current Research in Toxicology set out a framework for evaluating the safety of peptides used in cosmetics [6]. It shows how safety assessment for cosmetic peptides as a group is being approached.

Regulatory status (checked 19 October 2026). In the U.S., palmitoyl pentapeptide-4 is used as a cosmetic ingredient. It is not an FDA-approved drug. Cosmetics and most cosmetic ingredients do not receive FDA pre-market approval [7].

The cosmetic/drug line. Under U.S. law, a product's category depends on its intended use, which its claims can establish. Products intended to diagnose, treat or prevent disease, or to affect the structure or any function of the body, are drugs [7]. That is why compliant cosmetic labels talk about the appearance of lines rather than changes to skin biology.

Recent changes. The Modernization of Cosmetics Regulation Act of 2022 added duties for cosmetic companies. These include facility registration, product listing, adverse-event reporting and safety substantiation [8]. Our page on whether peptide serums are regulated walks through the cosmetic/drug line in more detail.

Entry 6: reading the label

What a label can and cannot tell you about this ingredient:

• Look for the INCI name, not the trade name. "Palmitoyl Pentapeptide-4" in the ingredient list confirms the molecule. A trade name on the front panel does not.

• Concentration is rarely disclosed. Labels seldom state the exact amount of any single ingredient. A prominent trade name on the front of the box says nothing about how much of the ingredient is inside.

• Watch for drug-style claims. Wording about rebuilding collagen or changing skin structure pushes a cosmetic toward drug territory under U.S. rules [7].

• "Clinically proven" needs a citation. Look for which study it was, which formula was tested, how many people took part and who ran it.

Tools for comparing products

Comparing cosmetic products is easier when every option is judged against the same neutral checklist. The criteria below focus on transparency rather than marketing language, and they apply to any serum or moisturizer on a retailer shelf.

Useful comparison points beyond the table: whether the listing names the market where the product is sold, and whether the brand answers questions about formulation openly.

Retailer listings vary in quality. The most useful ones show the complete ingredient list, the size, the market where the product is sold and the brand's contact details. Listings that rely on star ratings alone say very little about the formula.

Partners have no say over what we write. You can read more about how the site is funded and researched on our About page.

Frequently asked questions

Is Matrixyl the same thing as palmitoyl pentapeptide-4?

The original Matrixyl ingredient is palmitoyl pentapeptide-4, the INCI name for the palmitoylated KTTKS peptide. Related trade names with added numbers may contain different peptides. The ingredient list is the only dependable check.

How strong is the human evidence for palmitoyl pentapeptide-4?

The best-known human study is a 2005 vehicle-controlled split-face study in 93 adult women. It reported differences on wrinkle and fine-line measures over 12 weeks [1]. The study was industry-affiliated and has not been widely replicated independently, and much of the remaining literature is cell or chemistry work.

Is palmitoyl pentapeptide-4 an approved drug?

No. In the U.S. it is used as a cosmetic ingredient, and cosmetics do not receive FDA pre-market approval [7]. Claims about changing skin structure would move a product into the drug category.

Last updated: 19 October 2026.

Related on this site

• Skin Peptide Labs home

• Are peptide serums regulated? Cosmetic vs drug, decoded

• Peptides in skincare: a lab notebook guide to what works

• How to choose a peptide serum by reading the label

• Peptide moisturizer vs peptide serum: formats compared

• Best skincare books: a reader's guide to skin science and labels

• Peptides with retinol: what formulation research says about layering

Not medical advice. This page reports published research and regulatory records for information only.

Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.

Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.